China Pharma
(NYSEMKT) CPHI
China Pharma Financials at a Glance
Market Cap
$31.25M
Revenue (TTM)
$3.99M
Net Income (TTM)
-$3.55M
EPS (TTM)
-$0.55
P/E Ratio
-1.40
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Price
$0.77
Volume
33,394
Open
$0.86
Price
$0.77
Volume
33,394
Open
$0.86
Previous Close
$0.77
Daily Range
$0.74 - $0.86
52-Week Range
$0.38 - $2.03
Estimated Earnings Date
May 15, 2026
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Price
$0.77
Volume
33,394
Open
$0.86
Previous Close
$0.77
Daily Range
$0.74 - $0.86
52-Week Range
$0.38 - $2.03
Estimated Earnings Date
May 15, 2026
CPHI News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout China Pharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
221
CEO
Zhi Lin Li
Website
www.chinapharmaholdings.comHeadquarters
Haikou, 570216, CN
CPHI Financials
Key Financial Metrics (TTM)
Gross Margin
-13%
Operating Margin
-90%
Net Income Margin
-89%
Return on Equity
-16%
Return on Capital
-9%
Return on Assets
-8%
Earnings Yield
-71.43%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$31.25M
Shares Outstanding
40.52M
Volume
33.39K
Avg. Volume
278.94K
Financials (TTM)
Gross Profit
-$131.95K
Operating Income
-$3.09M
EBITDA
-$1.51M
Operating Cash Flow
$148.26K
Capital Expenditure
-$137.25K
Free Cash Flow
$11.01K
Cash & ST Invst.
$345.11K
Total Debt
$3.89M
China Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$983.54K
-13.4%
Gross Profit
-$539.80K
-296.7%
Gross Margin
-54.88%
N/A
Market Cap
$31.25M
N/A
Market Cap/Employee
$139.49K
N/A
Employees
224
N/A
Net Income
-$1.14M
-45.5%
EBITDA
-$136.55K
+68.1%
Quarterly Fundamentals
Total Cash
$168.47K
-59.2%
Total Debt
$3.56M
+1.5%
Accounts Receivable
$257.92K
-29.9%
Inventory
$1.50M
-24.1%
Long Term Debt
$92.29K
-93.4%
Short Term Debt
$3.47M
+64.0%
Return on Assets
-7.82%
N/A
Return on Invested Capital
-9.45%
N/A
Free Cash Flow
-$55.29K
+60.2%
Operating Cash Flow
-$55.29K
+4.4%